Evidence map›Paper›PMID 29589292›Full record

ArticleClinical drug investigation2018

Adherence to Antidepressants and Mortality in Elderly Patients with Cardiovascular Disease.

Annalisa Biffi, Lorenza Scotti, Federico Rea, Ersilia Lucenteforte, Alessandro Chinellato, Davide L Vetrano, Cristiana Vitale, Nera Agabiti, Janet Sultana, Giuseppe Roberto and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical drug investigation, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. All-cause mortality with current and past use of antidepressants or benzodiazepines after major osteoporotic and hip fracture.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2019
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 2 countries.

Annalisa BiffiLaboratory of Healthcare Research and Pharmacoepidemiology, Unit of Biostatistics, Epidemiology and Public Health, Department of Statistics and Quantitative Methods, University of Milano-Bicocca, Milan, Italy. a.biffi14@campus.unimib.it.
Lorenza ScottiLaboratory of Healthcare Research and Pharmacoepidemiology, Unit of Biostatistics, Epidemiology and Public Health, Department of Statistics and Quantitative Methods, University of Milano-Bicocca, Milan, Italy.
Federico ReaLaboratory of Healthcare Research and Pharmacoepidemiology, Unit of Biostatistics, Epidemiology and Public Health, Department of Statistics and Quantitative Methods, University of Milano-Bicocca, Milan, Italy.
Ersilia LucenteforteDepartment of Neurosciences, Psychology, Drug Research and Children's Health, University of Florence, Florence, Italy.
Alessandro ChinellatoTreviso Local Health Unit, Treviso, Italy.
Davide L VetranoDepartment of Geriatrics, Neurosciences and Orthopaedics, A. Gemelli University Hospital, Università Cattolica del Sacro Cuore, Rome, Italy.
Cristiana VitaleDepartment of Medical Sciences, IRCCS San Raffaele Pisana, Rome, Italy.
Nera AgabitiDepartment of Epidemiology, Lazio Regional Health Service, Roma, Italy.
Janet SultanaDepartment of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Messina, Italy.
Giuseppe RobertoEpidemiology Unit, Regional Agency for Healthcare Services of Tuscany, Florence, Italy.
Alessandro MugelliDepartment of Neurosciences, Psychology, Drug Research and Children's Health, University of Florence, Florence, Italy.
Giovanni CorraoLaboratory of Healthcare Research and Pharmacoepidemiology, Unit of Biostatistics, Epidemiology and Public Health, Department of Statistics and Quantitative Methods, University of Milano-Bicocca, Milan, Italy.
Italian Group for Appropriate Drug prescription in the Elderly (I-GrADE)
University of Milano-Bicocca · ITUniversità Cattolica del Sacro Cuore · ITUniversity of Florence · ITUniversity of Messina · ITAgenzia Regionale di Sanità della Toscana · ITAULSS 2 Marca Trevigiana · ITIRCCS Ospedale San Raffaele · IT

Funding

AIFA - the Italian Medicines Agency, Rome, Italy Project AIFA-FARM9LBBBL
6 · The paper itself

Abstract

BACKGROUND AND

objectiveConflicting findings from studies evaluating the association between use of antidepressant drugs and mortality have been reported. We tested the hypothesis that better adherence to antidepressant therapy may reduce mortality.

methodsThe cohort included 29,845 individuals aged ≥ 65 years from several Italian health units who were newly treated with antidepressant drugs after hospital discharge with a diagnosis for cardiovascular disease during 2008-2010. These individuals were observed from the first prescription until the end of data availability (i.e. 2012-2014, depending on the local database). During this period, information on (1) prescription of antidepressants and other medications and (2) death from any cause (outcome) was recorded. Proportional hazards models were fitted to estimate the association between better adherence to antidepressants (defined as proportion of days covered ≥ 75%) and outcome, by adjusting and stratifying for several covariates.

resultsPatients with better adherence to antidepressants had a reduced mortality of 9% (95% CI 3-14). Patients who did not use other medicaments during follow-up had reduced mortality associated with better adherence to antidepressants of 21% (- 1-38), 14% (7-20), 20% (13-26) and 13% (7-19) for no users of antihypertensive agents, lipid-lowering agents, other cardiovascular drugs and antidiabetics, respectively.

conclusionsBetter adherence to antidepressants is associated with reduced all-cause mortality, mainly in patients who did not use other pharmacological treatments. Behavioural changes to enhance adherence among the elderly with cardiovascular disease might offer important benefits in reducing their mortality.

Indexed as

Medication AdherenceAgedAged, 80 and overAntidepressive AgentsAntihypertensive AgentsCardiovascular DiseasesCohort StudiesDatabases, FactualFemaleFollow-Up StudiesHumansItalyMaleAntidepressive AgentsAntihypertensive Agents

Identifiers

PMID29589292
OpenAlexW2795342719

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.